Sequelae of SAR-CoV2 infection on Quality of Life and Lung

Not Applicable

• Conditions: Post SAR- CoV2 infection subjects; SAR- CoV2; Pulmonary Function; Quality of life; Respiraotry impairment

• Registration Number: TCTR20201006001
• Lead Sponsor: Ratchadapisek Sompoch Funding, Faculty of Medicine, Chulalongkorn University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-06
• Study Completion: 2021-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Enrolling by invitation
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. All subjects who had history of SAR-CoV2 infection
2. Age > 18 years
3. Be able to perform pulmonary function test

Exclusion Criteria

1. Has contraindication to perform pulmonary function test
2. Has active respiraotry infection
3. Terminal illness
4. No be able to follow up

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pulmonary functions (FEV1, FVC, DLCO) 12 months after admission Pulmonary function tests (FEV1, FVC, DLCO),Pulmonary functions (FEV1, FVC, DLCO) 3 months after admission Pulmonary function tests

Secondary Outcome Measures

Name	Time	Method
Qulatity of life 3 months after admission SGRQ, EQ5D,Functional capacity 3 months after admission 6MWT (m), SPPB,Qulatity of life 6,9,12 months after admission SGRQ, EQ5D,Functional capacity 6,9,12 months after admission 6MWT (m), SPPB